While general PET imaging faces challenges such as motion artifacts and truncation errors, the use of 68Ga-labeled Prostate-Specific Membrane Antigen (PSMA) tracers for prostate cancer imaging introduces additional complexities. This evidence concerns the gene FOLH1 and prostate cancer.